ReviewTherapeutic advances in hematology2020

Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia.

Yingyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.